(S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetate → (S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(3-methyl-[1,2,3]triazolo[1,5-a]pyridin-5-yl)benzo[d]thiazol-6-yl)acetate
Reaction equation
[C:1]([O:5][C@@H:6]([C:12]1[C:31]([CH3:32])=[CH:30][C:15]2[N:16]=[C:17]([C:19]3[CH:27]=[C:26]4[C:22]([C:23](C)=[N:24][N:25]4C)=[CH:21][CH:20]=3)[S:18][C:14]=2[C:13]=1[C:33]1[CH:38]=[CH:37][C:36]([Cl:39])=[CH:35][CH:34]=1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])([CH3:4])([CH3:3])[CH3:2].CC1[N:42]=NN2C=CC(B(O)O)=CC=12>>[C:1]([O:5][C@@H:6]([C:12]1[C:31]([CH3:32])=[CH:30][C:15]2[N:16]=[C:17]([C:19]3[CH:27]=[CH:26][N:25]4[N:24]=[N:42][C:22]([CH3:23])=[C:21]4[CH:20]=3)[S:18][C:14]=2[C:13]=1[C:33]1[CH:34]=[CH:35][C:36]([Cl:39])=[CH:37][CH:38]=1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])([CH3:3])([CH3:2])[CH3:4]Participants
3
Reactant 2
Product 1
Procedure
Prepared in a manner similar to (S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetate, but using 3-methyl-[1,2,3]triazolo[1,5-a]pyridin-5-ylboronic acid instead of 1,3-dimethyl-1H-indazol-6-ylboronic acid. 1H NMR (400 MHz, CDCl3) δ 8.68 (d, J=7.4 Hz, 1H), 8.21 (s, 1H), 7.91 (s, 1H), 7.66 (dd, J=7.4, 1.6 Hz, 1H), 7.61-7.50 (m, 3H), 7.50-7.43 (m, 1H), 5.17 (s, 1H), 4.27-4.17 (m, 2H), 2.67 (s, 3H), 2.62 (s, 3H), 1.30-1.22 (m, 3H), 0.99 (s, 9H).
Sources & evidence
- ORD record
- ord-a0887ae173a64da1bcd6ab9cc330243a
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08987250B2
Reaction notes
Loading…